Cargando…

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats

Serelaxin, a recombinant form of the naturally occurring peptide hormone relaxin-2, is a pleiotropic vasodilating hormone that has been studied in patients with acute heart failure. In this study, the effects of serelaxin on cardiac and renal function, fibrosis, inflammation and lipid accumulation w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dong, Luo, Yuhuan, Myakala, Komuraiah, Orlicky, David J., Dobrinskikh, Evgenia, Wang, Xiaoxin, Levi, Moshe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574886/ https://www.ncbi.nlm.nih.gov/pubmed/28851937 http://dx.doi.org/10.1038/s41598-017-09470-0

Ejemplares similares

The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
por: Wang, Dong, et al.
Publicado: (2018)

SRGAP2a: A New Player That Modulates Podocyte Cytoskeleton and Injury in Diabetes
por: Levi, Moshe, et al.
Publicado: (2018)

Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury
por: Song, Kai, et al.
Publicado: (2016)

The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress
por: Iyer, Abishek, et al.
Publicado: (2010)

Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats
por: Imenshahidi, Mohsen, et al.
Publicado: (2014)

EFFECTS OF CHRONIC EXCESS SALT INGESTION : ROLE OF GENETIC FACTORS IN BOTH DOCA-SALT AND RENAL HYPERTENSION
por: Dahl, Lewis K., et al.
Publicado: (1963)

Fibrosis quantification using multiphoton excitation imaging of picrosirius red stained cardiac tissue
por: Jones, Bryce A., et al.
Publicado: (2023)

Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats
por: Hemalatha, Govindasamy, et al.
Publicado: (2013)

Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats
por: Bae, Eun Hui, et al.
Publicado: (2019)

Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone
por: Moes, Arthur D., et al.
Publicado: (2018)

Captopril Alleviates Chondrocyte Senescence in DOCA-Salt Hypertensive Rats Associated with Gut Microbiome Alteration
por: Chan, Lok Chun, et al.
Publicado: (2022)

Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
por: Cerrudo, Carolina S., et al.
Publicado: (2021)

4528 Sirtuin 3 activation as a potential renoprotective therapy in a mouse model of Alport syndrome
por: Jones, Bryce, et al.
Publicado: (2020)

Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension
por: Amaral, Jefferson H., et al.
Publicado: (2015)

Mycophenolate Improves Brain–Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats
por: Robles-Vera, Iñaki, et al.
Publicado: (2020)

Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats
por: Robles-Vera, Iñaki, et al.
Publicado: (2021)

Adipose Mesenchymal Cells-Derived EVs Alleviate DOCA-Salt-Induced Hypertension by Promoting Cardio-Renal Protection
por: Lindoso, Rafael Soares, et al.
Publicado: (2019)

Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice
por: Wang, Haiping, et al.
Publicado: (2015)

PGC-1α overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice
por: Zhao, Qingbin, et al.
Publicado: (2015)

27558 Obeticholic acid (OCALIVA ®) protects against 2,8-dihydroxyadenine nephropathy in mice
por: Jones, Bryce, et al.
Publicado: (2021)

α-MSH Analogue Attenuates Blood Pressure Elevation in DOCA-Salt Hypertensive Mice
por: Rinne, Petteri, et al.
Publicado: (2013)

Effect of Scurrula atropurpurea on nitric oxide, endothelial damage, and endothelial progenitor cells of DOCA-salt hypertensive rats
por: Athiroh, Nour, et al.
Publicado: (2014)

Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension
por: Ma, Seong Kwon, et al.
Publicado: (2012)

ROS Suppression by Egg White Hydrolysate in DOCA-Salt Rats—An Alternative Tool against Vascular Dysfunction in Severe Hypertension
por: Abreu, Edina da Luz, et al.
Publicado: (2022)

Evidence of Cardiovascular Calcification and Fibrosis in Pseudoxanthoma Elasticum Mouse Models Subjected to DOCA-Salt Hypertension
por: Omarjee, Loukman, et al.
Publicado: (2019)

Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015)

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016)

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models
por: Tauber, Philipp, et al.
Publicado: (2021)

Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats
por: Szasz, Theodora, et al.
Publicado: (2013)

Role of aspirin activated nitric oxide synthase in controlling DOCA-salt-induced hypertension in rats through the stimulation of renal r-cortexin in kidney cortex cells
por: Maji, Uttam Kumar, et al.
Publicado: (2022)

Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice
por: Lyu, Bingqing, et al.
Publicado: (2020)

Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats
por: Dai, Shu-Yan, et al.
Publicado: (2015)

Interaction of central Angiotensin II and estrogen on systolic blood pressure in female DOCA-salt treated rats
por: Kafami, Marzieh, et al.
Publicado: (2016)

Myeloid Angiotensin II Type 1 Receptor Mediates Macrophage Polarization and Promotes Vascular Injury in DOCA/Salt Hypertensive Mice
por: Yang, Xue-Feng, et al.
Publicado: (2022)

Arterial expression of 5-HT(2B )and 5-HT(1B )receptors during development of DOCA-salt hypertension
por: Banes, Amy KL, et al.
Publicado: (2003)

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
por: Beldhuis, I. E., et al.
Publicado: (2023)

LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats via a NO Synthase-dependent Mechanism
por: Flahault, Adrien, et al.
Publicado: (2021)

The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
por: Wang, Xiaoxin X., et al.
Publicado: (2022)

Chronic Blockade of Brain Endothelin Receptor Type-A (ET(A)) Reduces Blood Pressure and Prevents Catecholaminergic Overactivity in the Right Olfactory Bulb of DOCA-Salt Hypertensive Rats
por: Cassinotti, Luis R., et al.
Publicado: (2018)

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
por: Liu, Licette C. Y., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qktvftesdu4uedu3kijp1d85g1